Skip to main content

Table 2 Analyses of treatment-related variables associated with recurrence/progression in MOGCTs

From: Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: A retrospective study of single institution

Variables No. Patients (%) Recurrence No
(Rate, %)
P value
Treatment modalities    
   Surgery only 8(14.0) 1(1.8) 0.4342
   Surgery + chemotherapy 49(86.0) 5(8.8)  
Operation methods    
   Fertility sparing 42(73.7) 1(1.8) 0.0006
Cystectomy without staging op. 1(1.8) 0(0.0)  
USO without staging op. 20(35.1) 0(0.0)  
USO with staging op. 21(36.8) 1(1.8)  
   Non-fertility sparing 15(26.3) 5(8.8)  
Hysterectomy + BSO without staging op. 5(8.8) 0(0.0)  
Hysterectomy + BSO with staging op. 10(17.5) 5(8.8)  
Chemotherapy regimens (n = 49)    
   BEP 9(18.4) 1(2.0) 0.9008
   EP 28(57.1) 3(6.1)  
   VBP 2(4.1) 0(0.0)  
   Others 10(20.4) 10(20.4)  
Residual lesions    
   None 47(82.5) 1(1.8) < 0.0001
   ≤ 1 cm 8(14.0) 3(5.3)  
   > 1 cm 2(3.5) 2(3.5)  
  1. USO, unilateral salpingo-oophorectomy; BSO, bilateral salpingo-oophorectomy; BEP, bleomycin, etoposide, and cisplatin; EP, etoposide and cisplatin; VBP, vinblastine, bleomycin, and cisplatin.